Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 732

1.

The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.

Liu L, Zhao Y, Jia J, Chen H, Bai W, Yang M, Yin Z, He C, Zhang L, Guo W, Niu J, Yuan J, Cai H, Xia J, Fan D, Han G.

Sci Rep. 2016 Feb 2;6:19851. doi: 10.1038/srep19851.

2.

Association of RNF43 with cell cycle proteins involved in p53 pathway.

Xie H, Xing C, Cao G, Wei B, Xu X, Song P, Chen L, Chen H, Yin S, Zhou L, Zheng S.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14995-5000. eCollection 2015.

3.

Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma.

Chedid MF, Scaffaro LA, Chedid AD, Maciel AC, Cerski CT, Reis MJ, Grezzana-Filho TJ, de Araujo A, Leipnitz I, Kruel CD, Alvares-da-Silva MR, Kruel CR.

Gastroenterol Res Pract. 2016;2016:9420274. doi: 10.1155/2016/9420274. Epub 2015 Dec 27.

4.

Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review.

Toda KS, Kikuchi L, Chagas AL, Tanigawa RY, Paranaguá-Vezozzo DC, Pfiffer T, Rocha Mde S, Alves VA, Carrilho FJ.

J Clin Transl Hepatol. 2015 Dec 28;3(4):260-4. doi: 10.14218/JCTH.2015.00027. Epub 2015 Dec 15.

5.

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review.

Marin D, Cappabianca S, Serra N, Sica A, Lassandro F, D'Angelo R, La Porta M, Fiore F, Somma F.

Gastroenterol Res Pract. 2015;2015:670965. doi: 10.1155/2015/670965. Epub 2015 Dec 22. Review.

6.
7.

Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future.

Soriano A, Varona A, Gianchandani R, Moneva ME, Arranz J, Gonzalez A, Barrera M.

World J Hepatol. 2016 Jan 8;8(1):58-68. doi: 10.4254/wjh.v8.i1.58. Review.

8.

Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Liu GJ, Wang W, Lu MD, Xie XY, Xu HX, Xu ZF, Chen LD, Wang Z, Liang JY, Huang Y, Li W, Liu JY.

Liver Cancer. 2015 Dec;4(4):241-52. doi: 10.1159/000367738. Epub 2015 Oct 21.

9.

Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.

Ahn DG, Kim HJ, Kang H, Lee HW, Bae SH, Lee JH, Paik YH, Lee JS.

Korean J Intern Med. 2016 Jan;31(1):46-53. doi: 10.3904/kjim.2016.31.1.46. Epub 2015 Dec 28.

10.

Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.

Chen QW, Li HJ, Chen YN, Ning ZY, Gao S, Shen YH, Meng ZQ, Vargulick S, Wang BY, Chen H.

PLoS One. 2016 Jan 14;11(1):e0139782. doi: 10.1371/journal.pone.0139782. eCollection 2016.

11.

Increased Risks of Spontaneous Bacterial Peritonitis and Interstitial Lung Disease in Primary Biliary Cirrhosis Patients With Concomitant Sjögren Syndrome.

Chen CT, Tseng YC, Yang CW, Lin HH, Chen PJ, Huang TY, Shih YL, Chang WK, Hsieh TY, Chu HC.

Medicine (Baltimore). 2016 Jan;95(2):e2537. doi: 10.1097/MD.0000000000002537.

12.

Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.

Han K, Kim JH, Ko GY, Gwon DI, Sung KB.

World J Gastroenterol. 2016 Jan 7;22(1):407-16. doi: 10.3748/wjg.v22.i1.407. Review.

13.

Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?

Park YS, Lee CH, Kim JW, Shin S, Park CM.

World J Gastroenterol. 2016 Jan 7;22(1):284-99. doi: 10.3748/wjg.v22.i1.284. Review.

14.

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W.

World J Gastroenterol. 2016 Jan 7;22(1):262-74. doi: 10.3748/wjg.v22.i1.262. Review.

15.

Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Hennedige T, Venkatesh SK.

World J Gastroenterol. 2016 Jan 7;22(1):205-20. doi: 10.3748/wjg.v22.i1.205. Review.

16.

Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair.

Shao J, Xu Z, Peng X, Chen M, Zhu Y, Xu L, Zhu H, Yang B, Luo P, He Q.

PLoS One. 2016 Jan 11;11(1):e0146968. doi: 10.1371/journal.pone.0146968. eCollection 2016.

17.

The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.

Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H.

PLoS One. 2016 Jan 8;11(1):e0146456. doi: 10.1371/journal.pone.0146456. eCollection 2016.

18.

Addition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma.

Monsignore LM, Elias-Junior J, Muglia VF, Teixeira AC, Mente ED, Martinelli Ade L, Abud DG.

Clinics (Sao Paulo). 2015 Dec;70(12):781-9. doi: 10.6061/clinics/2015(12)04.

19.

Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy.

Belli A, Cioffi L, Russo G, Belli G.

Hepatobiliary Surg Nutr. 2015 Dec;4(6):417-21. doi: 10.3978/j.issn.2304-3881.2015.12.02.

20.

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil.

Ueshima K, Kudo M, Tanaka M, Kumada T, Chung H, Hagiwara S, Inoue T, Yada N, Kitai S.

Liver Cancer. 2015 Dec;4(4):263-73. doi: 10.1159/000367751. Epub 2015 Oct 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk